How often does Nurix Therapeutics move more than the options market prices?

0 of the last 8 reports moved at least as far as the implied move.

NRIXNasdaqPharmaceutical Preparations

Nurix Therapeutics, Inc. (NRIX) earnings date, market-implied expected move, and options open interest by expiry

26.80

−0.32 · −1.20%

post 26.85 +0.21%

Closed19:53 ET

Open26.76Volume2.3MMkt cap$2.9BP/E10.74EPS2.50

Day26.12 – 27.0083%52-wk11.67 – 28.2392%

NRIX

Nurix Therapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Jan 27

after close · in 87 days

est.Q4 FY26

Calendar

Next report

Last report

−0.14%

vs ±17.9% implied · ×0.01

shaded = implied · ▲▼ = realized

Oct 13 '26 · confirmed

Implied vs realized

Linked news

1dGILD · customerGilead Sciences to Present at Upcoming Fourth Quarter 2026 Investor Conferences
1dSNY · customerSanofi Q3 sales €14,444 million, business EPS €3.55; upgrades 2026 guidance

News

Largest filed tie

13F top-10 QoQ

+17.35%

shares held · 10 largest managers

13F · Jun 30 '26124d lag

212 managers

Top fund weight

0.56%

NRIX weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Nurix Therapeutics (NRIX) is expected to report on Jan 27 after close (estimated date).

Implied vs realized

8 reports

0 of 8≥ implied

avg implied: ±19.2%
avg realized: ±3.9%

Jan 28 '25Jan 28 '25confirmed±12.1%▲+0.46%×0.04

Apr 8 '25Apr 8 '25confirmed±33.4%▲+3.67%×0.11

Jul 9 '25Jul 9 '25confirmed±13.5%▼−3.87%×0.29

Oct 9 '25Oct 9 '25confirmed±17.0%▼−10.13%×0.60

Q1 FY26Jan 28 '26confirmed±17.3%▼−1.57%×0.09

Apr 8 '26Apr 8 '26confirmed±25.7%▼−4.59%×0.18

Q2 FY26Jul 9 '26confirmed±16.5%▼−6.60%×0.40

Q3 FY26Oct 13 '26confirmed±17.9%▼−0.14%×0.01

quarterimplied−35%0+35%realized×

Q3 FY26±17.9%▼−0.14%×0.01

Q2 FY26±16.5%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Oct 23 close

1.06OI · 4 expiries · Oct 23 closeP/C open interest · Apr 16 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

340+4%Nov 2019d0.37917+173%0.37

3—Dec 1847d0.0557—0.05

1,098+59%Jan 1575d0.771,427+54%0.77

report · Jan 27 · after close · est.

815—Apr 16166d769—

ExpiryPutsCallsP/C

Nov 2019d340+4%917+173%0.37

Dec 1847d3—57—0.05

Jan 1575d1,098+59%1,427+54%0.77

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ3 FY26

81.69%as filednet margin · revenue +7342.93% QoQ · +8426.27% YoY

Revenue

$673M+7342.93% QoQ

Gross profit

$673M+7342.93% QoQ

100.00% margin

Operating income

$559M+693.87% QoQ

83.12% margin

Pre-tax income

$563M+727.37% QoQ

Net income

$550M+714.07% QoQ

81.69% margin

Operating expenses

$114M+10.04% QoQ

R&D $79M

SG&A $34M

Tax

$14M+5120.66% QoQ

Other income

$4M−9.91% QoQ

Revenue$673M+7342.93%

Gross profit

$673M+7342.93%

100.00% margin

Operating income

$559M+693.87%

83.12% margin

Pre-tax income

$563M+727.37%

Net income

$550M+714.07%

81.69% margin

Cost of revenue

Operating expenses

$114M+10.04%

R&D $79M

SG&A $34M

Other income$4M−9.91%

Tax$14M+5120.66%

flow · deduction · inflow · signed % = QoQSource: SEC filings · standardized · QE Aug 31 '26 · width = $

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 19:45 ET

Intraday

Event sensitivity

CPROF ×1.07· ±3.3% vs ±3.1% · 12 releases

eventrelease day|move|up · n×base

CPROFcorporate profits±3.3%7 of 12×1.07

PPIproducer prices±3.3%6 of 10×1.06

GDPgross domestic product±2.9%9 of 19×0.93

PCEpersonal income & outlays±2.6%9 of 19×0.83

FOMCrate decision±2.5%14 of 24×0.79

NFPjobs report±1.9%5 of 10×0.62

CPIconsumer prices±1.7%4 of 10×0.55

Bar = avg |move| to ±4% · tick = ±3.1% avg day · ×base = |move| ÷ ±3.1% · min 6 releases

Earnings history

EPS 4.73 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	Oct 13 '26 · confirmed	4.73	—
Q2 FY26	Jul 9 '26 · confirmed	-0.81	—
Q1 FY26	Jan 28 '26 · confirmed	-0.79	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod